Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Luke Thomas Charles Create: Alert

All | News | Filings
Date FiledTypeDescription
03/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/26/2021 4 Luke Thomas Charles (Chief Medical Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 990 shares @ $10.1, valued at $10k
Granted 5,428 shares @ $0
Granted 2,193 options to buy @ $0
Granted 139,585 options to buy @ $1, valued at $139.6k
Granted 11,632 options to buy @ $1.25, valued at $14.5k
Granted 61,092 options to buy @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy